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ABSTRACT Molecular determinants essential for skeletal-type excitation-contraction (EC) coupling have been described in
the cytosolic loops of the dihydropyridine receptor (DHPR) a1S pore subunit and in the carboxyl terminus of the skeletal-speciﬁc
DHPR b1a-subunit. It is unknown whether EC coupling domains present in the b-subunit inﬂuence those present in the pore
subunit or if they act independent of each other. To address this question, we investigated the EC coupling signal that is
generated when the endogenous DHPR pore subunit a1S is paired with the heterologous heart/brain DHPR b2a-subunit.
Studies were conducted in primary cultured myotubes from b1 knockout (KO), ryanodine receptor type 1 (RyR1) KO, ryanodine
receptor type 3 (RyR3) KO, and double RyR1/RyR3 KO mice under voltage clamp with simultaneous monitoring of confocal
ﬂuo-4 ﬂuorescence. The b2a-mediated Ca21 current recovered in b1 KO myotubes lacking the endogenous DHPR b1a-subunit
veriﬁed formation of the a1S/b1a pair. In myotube genotypes which express no or low-density L-type Ca21 currents, namely b1
KO and RyR1 KO, b2a overexpression recovered a wild-type density of nifedipine-sensitive Ca21 currents with a slow activation
kinetics typical of skeletal myotubes. Concurrent with Ca21 current recovery, there was a drastic reduction of voltage–
dependent, skeletal-type EC coupling and emergence of Ca21 transients triggered by the Ca21 current. A comparison of b2a
overexpression in RyR3 KO, RyR1 KO, and double RyR1/RyR3 KO myotubes concluded that both RyR1 and RyR3 isoforms
participated in Ca21-dependent Ca21 release triggered by the b2a-subunit. In b1 KO and RyR1 KO myotubes, the Ca21-
dependent EC coupling promoted by b2a overexpression had the following characteristics: 1), L-type Ca21 currents had a wild-
type density; 2), Ca21 transients activated much slower than controls overexpressing b1a, and the rate of ﬂuorescence increase
was consistent with the activation kinetics of the Ca21 current; 3), the voltage dependence of the Ca21 transient was bell-
shaped and the maximum was centered at ;130 mV, consistent with the voltage dependence of the Ca21 current; and 4),
Ca21 currents and Ca21 transients were fully blocked by nifedipine. The loss in voltage-dependent EC coupling promoted by
b2a was inferred by the drastic reduction in maximal Ca21 ﬂuorescence at large positive potentials (DF/Fmax) in double
dysgenic/b1 KO myotubes overexpressing the pore mutant a1S (E1014K) and b2a. The data indicate that b2a, upon interaction
with the skeletal pore subunit a1S, overrides critical EC coupling determinants present in a1S. We propose that the a1S/b pair,
and not the a1S-subunit alone, controls the EC coupling signal in skeletal muscle.
INTRODUCTION
Excitation-contraction (EC) coupling in striated muscle
is a fast process in which a brief depolarization causes
an immediate elevation of the cytosolic Ca21 (Kim and
Vergara, 1998). This process is brought about by a close
interaction between the dihydropyridine receptor (DHPR) L-
type Ca21 channel and the ryanodine receptor type 1 (RyR1)
in skeletal muscle or type 2 (RyR2) in cardiac muscle. Close
proximity between the DHPR and RyR complexes occurs at
specialized junctions established between the transverse
tubular and sarcoplasmic reticulum (SR) membranes (Fran-
zini-Armstrong and Protasi, 1997). At these junctions,
voltage-dependent movements of electrical charges in the
skeletal DHPR are coupled to the opening of the RyR1
channel. However, the molecular mechanism that opens the
RyR1 channel, including which DHPR subunits directly
contribute to this process, is, for the most part, unknown. In
contrast, activation of RyR2 channels in cardiac muscle is
a Ca21-dependent process and is strictly proportional to the
magnitude of the L-type Ca21 current (Beuckelmann and
Wier, 1988; Bers, 2002). This fundamental difference in EC
coupling trigger mechanism leads to signiﬁcant differences
in the voltage-dependence of Ca21 transients. In skeletal
muscle, the Ca21 transient amplitude versus voltage re-
lationship is sigmoidal whereas in cardiac muscle, it is bell-
shaped such that the Ca21 transient is always proportional
to the Ca21 current. The biophysical and molecular details
of SR Ca21 release mediated by skeletal and cardiac RyR
isoforms have been reviewed extensively (McPherson and
Campbell, 1993; Coronado et al., 1994; Meissner, 1994;
Sutko and Airey, 1996; Fill and Copello, 2002).
In molecular terms, the skeletal DHPR is an ;430-kDa
heteropentamer composed of a1S, b1a, a2-d1, and g1
subunits. The DHPR a1-subunit belongs to the superfamily
of voltage-gated channel proteins with four internal repeats.
Electrical charges in the S4 segments in each repeat move
outward in response to membrane depolarization. This
movement is coupled to the opening of the channel
(Bezanilla, 2000). b-subunits are ;65-kDa proteins that
bind strongly to the cytosolic loop between repeats I and II of
a1 via a conserved;30-residue b interaction domain or BID
(Pragnell et al., 1994; De Waard et al., 1994). b-subunits
modulate the kinetics of activation and inactivation of the
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Ca21 current (Qin et al., 1996; Wei et al., 2000; Berrou et al.,
2001) and strengthen the coupling between S4 charge
movements and pore opening (Neely et al., 1993; Olcese
et al., 1996; Kamp et al., 1996). The molecular structure and
function of the a2-d1 and g1 subunits of the skeletal DHPR
are far less deﬁned (Gurnett et al., 1996; Ahern et al., 2001c;
Arikkath et al., 2003).
Molecular studies of the EC coupling mechanism have
relied on myotube models lacking speciﬁc DHPR subunits
and RyR isoforms. Tanabe et al. (1988) utilized the a1S-null
dysgenic myotube to show that the a1S pore subunit was
essential for EC coupling signaling. In the dysgenic
myotube, a base deletion leads to truncation and degradation
of a1S and loss of voltage-activated Ca21 transients.
Transfection of cultured dysgenic myotubes with a1S cDNA
leads to de novo synthesis of a1S-subunits (Ahern et al.,
2001a,d), concentration of the expressed DHPR in EC
coupling junctions (Takekura et al., 1994), and recovery of
skeletal type EC coupling (Garcia et al., 1994). This
expression system permitted studies in which the missing
a1S Ca21 pore isoform was replaced by a1C, the cardiac/
brain pore variant (Tanabe et al., 1990). The Ca21
ﬂuorescence versus voltage curve expressed by a1C in
dysgenic myotubes had a maximum at ;130 mV followed
by a continuous decrease at more positive potentials. The
biphasic nature of this relationship, along with a dependence
of Ca21 transients on external Ca21, showed that Ca21-
dependent EC coupling could be implemented in skeletal
myotubes by a hybrid DHPR composed of a cardiac pore
subunit and the nonpore subunits expressed endogenously in
the dysgenic myotube. The expression of chimeras of a1S
and a1C were later used to demonstrate that a domain within
the cytosolic loop linking repeats II and III of a1S (a1S
L720–Q765) harbored a unique signal essential for skeletal
type EC coupling (Nakai et al., 1998a). The studies in
dysgenic myotubes have led to the view that the a1S-subunit
is the major contributor to the signal transduction and that the
a1S II-III loop may be directly responsible for opening
RyR1. However, in a strict sense, the observations in dys-
genic myotubes cannot exclude the participation of other
DHPR subunits in the EC coupling signal since these
subunits (a2-d1,b, g1) are constitutively expressed in the dys-
genic myotube (Arikkath et al., 2003). Hence, if EC coupling
domains were to be present in other subunits of the skeletal
DHPR, they would have escaped detection in the dysgenic
myotube by virtue of being constitutively present. In support
of this premise, deletion analysis of the critical a1S L720–
Q765 domain suggests that regions other than a1S II-III loop
participate in skeletal-type EC coupling (Ahern et al.,
2001b).
Gene targeting techniques have substantially increased the
number of myotube models that can be used as expression
platforms for EC coupling studies. Gregg et al. (1996)
described a knockout (KO) of the mouse b1 gene, encoding
DHPR b isoforms expressed in skeletal muscle (b1a) and
brain (b1b, b1c) (Powers et al., 1992). The b1 KO mutation,
like the dysgenic mutation, is perinatally lethal due to the
absence of EC coupling in the skeletal musculature. The b1
KO myotubes fail to contract in response to electrical
stimulation despite the presence of normal action potentials,
Ca21 storage capacity, and caffeine-sensitive Ca21 release.
However, b1 KO cells lack L-type Ca21 current, and
depolarization does not produce Ca21 transients (Gregg et al.,
1996; Strube et al., 1996). Expression of the skeletal muscle
b1a isoform in cultured b1 KO myotubes resulted in the
recovery of the wild-type (WT) L-type Ca21 current density,
the intramembrane charge movement density, and the
amplitude and voltage dependence of Ca21 transients (Beurg
et al., 1997). In contrast, expression of the cardiac/brain b2a
variant recovered L-type Ca21 currents, but the amplitude of
depolarization-activated Ca21 transients was drastically
depressed. Because the interaction between the DHPR a1-
and b-subunits is essential for cell surface expression (Chien
et al., 1995; Bichet et al., 2000), the loss of EC coupling in
the b1 KO myotube could be exclusively due to the loss of
DHPR voltage sensors from the cell surface. Alternatively,
domains of the DHPR b1a-subunit, similar to elements
present in the a1S-subunit, might be directly involved in
activation of RyR1 channels. To examine the role of DHPR
b1a in skeletal-type EC coupling, we chimerized b1a and the
cardiac/brain b2a variant and mapped the domain(s) required
for functional recovery of skeletal-type EC coupling in
cultured b1 KO myotubes (Beurg et al., 1999a,b; Sheridan
et al., 2003a). DHPR b-subunits share two conserved central
regions amounting to more than half of the total peptide
sequence (domains D2 and D4), a nonconserved linker
between the two conserved domains (D3), a nonconserved
amino terminus (D1), and a nonconserved carboxyl terminus
(D5) (Perez-Reyez and Schneider, 1994). We tested the
participation of D1, D3, and D5 of b1a in the recovery of
Ca21 conductance, charge movements, and EC coupling in
b1 KO skeletal myotubes (Beurg et al., 1999a; Sheridan
et al., 2003a). Deletion of the D5 region of b1a (b1a residues
470–524) drastically reduced the amplitude of voltage-
evoked Ca21 transients without affecting the density of
DHPR charge movements. Thus, the membrane density of
DHPR voltage sensors, critical for voltage-dependent EC
coupling, was not compromised by the carboxyl terminal
deletion. On the basis of this result, we have implicated the
D5 region of b1a speciﬁcally in skeletal-type EC coupling
(Sheridan et al., 2003a). Recent recombinant protein binding
studies indicate that the D5 domain is essential for strong
interaction between DHPR b1a and a speciﬁc cytoplasmic
region of RyR1 (Cheng and Coronado, 2003).
Targeted disruption of the three mammalian RyR genes
has been described (Takeshima et al., 1994, 1996; Nakai et al.,
1996; Bertocchini et al., 1997). Two of these variants, namely
RyR1 and RyR3, contribute to EC coupling in skeletal
muscle. Absence of RyR1 leads to a full loss of skeletal-type
EC coupling. Therefore, the RyR1 KO mutation is also
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perinatally lethal. Moreover, transient expression of RyR2 or
RyR3 in the RyR1-deﬁcient myotube does not lead to
a recovery of skeletal EC coupling function (Yamazawa et al.,
1996; Nakai et al., 1997; Fessenden et al., 2000). In contrast
to RyR1-deﬁciency, RyR3-deﬁciency affects dynamic as-
pects of muscle tension during the embryonic stage and slows
Ca21 transient propagation (Bertocchini et al., 1997; Yang
et al., 2001). However, RyR3 is not essential for mouse
survival. Such a nonequivalent behavior of RyR1 and RyR3
variants suggests that highly speciﬁc interactions between
RyR1 and the skeletal DHPR are essential for Ca21 signaling
in skeletal myotubes. This notion has been corroborated by
the identiﬁcation of RyR1 domains involved in skeletal-type
EC coupling using chimeras of RyR1 and RyR2 or RyR1 and
RyR3 (Yamazawa et al., 1997; Nakai et al., 1998b; Perez
et al., 2003).
In this study, we used KO myotubes lacking DHPR b1,
RyR1, and RyR3 to examine the characteristics of the EC
coupling induced by the heterologous cardiac/brain b2a
variant in the context of myotubes expressing a WT a1S-
subunit. This interest was prompted by the observation that
many of the carboxyl terminal deletion mutants of the D5
region of b1a, when expressed in b1 KO myotubes, induced
Ca21 transients triggered by the Ca21 current (Sheridan et al.,
2003a). Hence, the EC coupling mechanism induced by the
modiﬁed skeletal b1a variants shared many characteristics
with the EC coupling process described in the heart. This
result begs the question of whether a heterologous DHPR b
variant from a gene predominantly expressed in cardiac
tissues might be able to transform the skeletal EC coupling
process to one more closely resembling cardiac EC coupling.
We show that overexpression of the WT cardiac/brain b2a
variant (Perez-Reyez and Schneider, 1994) produces drastic
changes in EC coupling characteristics of cultured skele-
tal myotubes, altering it from a purely voltage-dependent
process to one controlled mostly by the Ca21 current. The
changes are functionally equivalent to those observed in
dysgenic myotubes expressing the cardiac/brain a1C variant
in the context of the WT DHPR b1a-subunit. The results are
consistent with the view that the DHPR b-subunit, like a1, is
a key structural determinant of EC coupling in muscle cells.
Part of this work has been previously published in abstract
form (Sheridan et al., 2002, 2003b).
MATERIALS AND METHODS
Identiﬁcation of genotypes
We used polymerase chain reaction (PCR) assays to screen for the WT and
mutant alleles of the DHPR a1S, b1, RyR1, and RyR3 genes in mice with
targeted disruptions of these genes (Gregg et al., 1996; Nakai et al., 1996;
Bertocchini et al., 1997) or, in the case of muscular dysgenesis mice (mdg),
carrying a frame-shifted a1S-null gene (Chaudhari, 1992). Tail samples
were digested with proteinase K (Sigma, St. Louis, MO), and the DNA was
then isolated following the Puregene animal tissue protocol (Gentra
Systems, Minneapolis, MN). The PCR reactions for each sample were
composed of 11.7 mL distilled water, 1 mL of each 20 mM primer, 3.2 mL of
1.25 mM dNTPs (Stratagene, Cedar Creek, TX), 2 mL 103 PCR buffer
(Qiagen, Valencia, CA), 1.2 mL Taq polymerase (Qiagen), and 1 mL of the
DNA sample (;100 mg/mL).
DHPR a1S alleles
PCR primers 59 ttt ccc aca ggc cgt gct gct gct ctt ca 39 and 59 gca gct ttc cac
tca gga ggg atc cag tgt 39 were used to amplify a 202-bp fragment of the WT
a1S allele. PCR primers 59 gca gct ttc cac tca gga ggg atc cag tgt 39 and 59 ttt
ccc aca ggc cgt gct gct gct ctt aga 39 were used to amplify a 203-bp fragment
of the mdg allele (a1S-null). The following conditions apply for the PCR of
both DHPR a1S alleles: 1), 2 min at 948C; 2), 45 s at 948C; 3), 45 s at 608C;
4), 1 min at 728C; 5), cycle through steps 2–4 for 30 times; and 6), 10 min at
728C.
DHPR b1 alleles
PCR primers 59 gag aga cat gac aga ctc agc tcg gag a 39 and 59 aca ccc cct
gcc agt ggt aag agc 39 were used to amplify a 250-bp fragment of the WT b1
allele. PCR primers 59 aca ccc cct gcc agt ggt aag agc 39 and 59 aca ata gca
ggc atg ctg ggg atg 39 were used to amplify a 197-bp fragment of the KO b1
allele. The following conditions apply for the PCR of both DHPR b1 alleles:
1), 2 min at 948C; 2), 30 s at 948C; 3), 45 s at 608C; 4), 1 min at 728C; 5),
cycle through steps 2–4 for 30 times; and 6), 10 min at 728C.
RyR1 alleles
PCR primers 59 gga ctg gca aga gga ccg gag 39 and 59 gga agc cag ggc tgc
agg tga gc 39 were used to amplify a 400-bp fragment of the WT RyR1
allele. PCR primers 59 gga ctg gca aga gga ccg gag 39 and 59 cct gaa gaa cga
gat cag cag cct ctg ttc c 39were used to amplify a 300-bp fragment of the KO
RyR1 allele. The following conditions applied for the PCR of both RyR1
alleles: 1), 5 min 30 s at 948C; 2), 1 min at 948C; 3), 1 min at 578C; 4), 1 min
at 728C; 5), cycle through steps 2–4 for 35 times; and 6), 10 min at 728C.
RyR3 alleles
PCR primers 59 cac atc cca atc tcc ttt act cc 39 and 59 gct tat tct gcc cta atg cca
c 39 were used to amplify a 316-bp fragment of the WT RyR3 allele. PCR
primers 59 ggt cat cct cac ttc gcc tat gtt c 39 and 59 cgt gct act tcc att tgt cac
gtc 39 were used to amplify a 920-bp fragment of the KO RyR3 allele. The
following conditions apply for the PCR of both RyR3 alleles: 1), 2 min at
948C (hot start followed by addition of Taq polymerase (Qiagen); 2), 3 min
at 948C; 3), 1 min at 588C; 4), 2 min at 728C; 5), cycle through steps 2–4 for
35 times; and 6), 10 min at 728C.
Primary cultures
Cultures of myotubes were prepared from hind limbs of E18 fetuses, as
described previously (Beurg et al., 1997). Muscles dissected from the fetuses
were treated with 0.125% (w/v) trypsin and 0.05% (w/v) pancreatin. After
centrifugation, mononucleated cells were resuspended in plating medium
containing 78% Dulbeccos’s modiﬁed Eagle’s medium with low glucose
(DMEM), 10% horse serum, 10% fetal bovine serum (FBS), and 2% chicken
serum extract. Cells were plated on plastic culture dishes coated with gelatin
at a density of ;1 3 104 cells per dish. Cultures were grown at 378C in 8%
CO2 gas. After myoblast fusion (;6 days), the medium was replaced with
FBS free medium, and CO2 was decreased to 5%.
Double a1S/b1-null myotubes
E18 fetuses lacking a1S and b1a were obtained by screening litters of
fetuses from crosses of double heterozygous dysgenic and b1 KO mice
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(a1S1/mdg, b11/ 3 a1S1/mdg, b11/) as described (Ahern et al., 1999;
2003). Mutant fetuses were visually recognized by the absence of muscle
movements and were separately processed for myotube cell culture while
a PCR screen was conducted in parallel. Limb myotube cultures from double
null E18 fetuses with the genotype a1Smdg/mdg, b1/ were utilized in
cDNA transfection protocols and are identiﬁed in the text as double
dysgenic/b1 KO myotubes.
cDNA transfection
cDNA transfection was performed during the myoblast fusion stage with the
polyamine LT1 (Panvera, Madison, WI). Cells were exposed for 2–3 h to
a transfection solution containing LT1 and cDNA at a 5:1 mg ratio. In
addition to the cDNA of interest, cells were cotransfected with a plasmid
encoding the T-cell protein CD8, which is used as a transfection marker.
Transfected myotubes expressing CD8 were recognized by surface binding
of polystyrene beads coated with a monoclonal antibody speciﬁc for an
external CD8 epitope (Dynal ASA, Oslo, Norway). The efﬁciency of
cotransfection of the marker and the cDNA of interest was ;90%. Whole-
cell analysis of Ca21 currents and Ca21 transients was performed 3–5 days
after transfection.
cDNA constructs
cDNAs for mouse b1a (residues 1–524; GenBank accession no.
NM_031173) and rat b2a (residues 1–604; GenBank accession no.
M80545) were subcloned into the pCR-Blunt vector (Invitrogen, Carlsbad,
CA), excised by digestion with AgeI and NotI, and cloned into the pSG5
vector in frame with the ﬁrst 11 residues of the phage T7 gene 10 protein for
antibody tagging. The a1S (E1014K) substitution was introduced in a rabbit
a1S template (GenBank accession no. M23919) and was described
previously (Ahern et al., 2001b). WT a1S and a1S (E1014K) were fused
in-frame to the ﬁrst 11 amino acids of the phage T7 gene 10 protein in the
pSG5 vector.
Whole-cell voltage clamp
Whole-cell recordings were performed as described previously (Strube et al.,
1996)with anAxopatch 200B ampliﬁer (Axon Instruments, Foster City, CA).
Effective series resistance was compensated up to the point of ampliﬁer
oscillationwith theAxopatch circuit.All experimentswere performedat room
temperature. The external solution was (in mM) 130 TEA methanesulfonate,
10 CaCl2, 1 MgCl2, 10
3 TTX, 10 HEPES titrated with TEA(OH) to pH 7.4.
The pipette solution consisted of (in mM) 140 Cs aspartate, 5 MgCl2, 0.1
EGTA (when Ca21 transients were recorded) or 5 EGTA (when only Ca21
currents were recorded), and 10 MOPS titrated with CsOH to pH 7.2. Patch
pipettes had a resistance of 1–1.5 MV when ﬁlled with the pipette solution.
The limit of Ca21 current detection was;20 pA/cell or;0.05 pA/pF for the
smallest cells having the lowest capacitative noise.
Confocal ﬂuorescence microscopy
Confocal line scan measurements were performed as described previously
(Conklin et al., 1999). All experiments were performed at room temperature.
Cells were loaded with 5 mM ﬂuo-4 acetoxymethyl (AM) ester (Molecular
Probes, Eugene, OR) for 60 min at room temperature. Cells were viewed
with an inverted Olympus microscope with a 203 objective (N.A. ¼ 0.4)
and a Fluoview confocal attachment (Olympus, Melville, NY). A 488-nm
spectrum line for ﬂuo-4 excitation was provided by a 5-mW Argon laser
attenuated to 6% with neutral density ﬁlters. For voltage-activated Ca21
transients, line scans consisted of 1000 lines, each of 512 pixels, acquired at
a rate of 2.05 milliseconds per line. Line scans were synchronized to start
100 ms before the onset of the depolarization. For Ca21 transients activated
by caffeine or CMC (4-chloro-m-cresol, Sigma, St. Louis, MO), line scans
consisted of 1000 lines, each of 512 pixels, acquired at a rate of 30.8
milliseconds per line. Line scans were synchronized to start 800 ms before
the onset of the external solution change. The time course of the space-
averaged ﬂuorescence intensity change and DF/F units were estimated as
follows: 1), The pixel intensity in a line scan was transformed into arbitrary
units, and the mean intensity of each line was obtained by averaging pixels
covering the cell exclusively; 2), The mean resting ﬂuorescence intensity (F)
corresponds to the mean intensity of each line averaged before stimulation
and was used as a baseline; 3), The change in mean line intensity above
baseline (DF) was obtained by subtraction of F (baseline) from the mean line
intensity; 4), DF was divided by the baseline F for each line in a line scan
and was plotted as a function of time. The peak-to-peak noise in the baseline
ﬂuorescence averaged ;0.1 DF/F units which was previously estimated
to correspond approximately to a 200-nM change in free Ca21 (Conklin
et al., 1999). Since DF/F was spatially averaged, noise varied with spa-
tial inhomogeneities in ﬂuo-4 ﬂuorescence and cell size. The smallest
ﬂuorescence signals reported in this study were ;0.2 DF/F in b2a-
overexpressing RyR1/RyR3 KO myotubes and ;0.4 DF/F in b2a-
overexpressing RyR1 KO myotubes (Table 2). To construct peak Ca21
ﬂuorescence versus voltage curves, we used the highestDF/F line value after
the onset of the pulse and up to the termination of the pulse. Image analyses
were performed with NIH Image software (National Institutes of Health,
Bethesda, MD). To obtain reliable Ca21 transient versus voltage curves,
seven-step depolarizations of 50 ms or 200 ms were applied in descending
order (from 190 mV to 30 mV) from a holding potential of 40 mV.
Between each depolarization, the cell was maintained at the resting potential
for 30 s to permit recovery of the resting ﬂuorescence.
Immunostaining
Four to ﬁve days after transfection, cells were ﬁxed in 100% methanol and
processed for immunostaining as described previously (Gregg et al., 1996).
The primary antibody was a mouse monoclonal against the T7 epitope
(Novagen, Madison, WI) present in b1a and b2a and was used at a dilution
of 1:1000. The secondary antibody was a ﬂuorescein conjugated polyclonal
goat anti-mouse IgG (Boehringer Mannheim, Indianapolis, IN) and was
used at a dilution of 1:1000. Confocal images of 0.3 to 0.4 microns per pixel
were obtained in the Olympus Fluoview using a 403 oil-immersion
objective (N.A.¼ 1.3). Images were Kalman-averaged 3 times, and the pixel
intensity was displayed as 16 levels of gray in reverse. All images were
acquired with minimal laser power (6% of maximum 5 mW) and
predetermined PMT settings to avoid pixel saturation and for accuracy in
the comparison of images.
Curveﬁtting
The voltage dependence of the Ca21 conductance and peak ﬂuorescence,
assayed with the 50-ms depolarization, was ﬁtted in all cases according to
a Boltzmann distribution (Eq. 1)
A ¼ Amax=ð11 expððV  V1=2Þ=kÞÞ
where Amax is Gmax or DF/Fmax, V1/2 is the potential at which A ¼ Amax/2,
and k is the slope factor. For myotubes overexpressing b1a, the voltage
dependence of peak ﬂuorescence assayed with a 200-ms depolarization was
ﬁt with Eq. 1. The b2a variant produced biphasic bell-shaped ﬂuorescence
versus voltage curves with varying degrees of curvature. For myotubes
overexpressing b2a, the voltage dependence of peak intracellular Ca21
assayed with a 200-ms depolarization was ﬁt with the modiﬁed Boltzmann
distribution (Eq. 2)
DF=F ¼ ðV  VrÞ=k9½DF=Fmax=ð11 expðV  V1=2Þ=kÞ;
where (VVr) is a factor that accounts for the decrease in Ca21 current
trigger at positive potentials and k9 is a scaling factor that varies with the
magnitude of DF/Fmax. Other parameters are the same as in Eq. 1.
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Parameters of a ﬁt of averages of many cells (population average) are shown
in ﬁgures. The statistics of parameters of the ﬁt of individual cells are shown
in Table 1. Student’s t-tests and analysis of variance (ANOVA) were
performed with Analyze-it software (Analyze-it, Leeds, UK).
RESULTS
Previous studies showed that b1 KO myotubes express-
ing the heterologous DHPR b2a-subunit had weak Ca21
transients compared to controls expressing the skeletal
muscle-speciﬁc b1a-subunit (Beurg et al., 1999a,b; Sheridan
et al., 2002, 2003b). Here we demonstrate that b2a induces
Ca21 transients triggered by the Ca21 current, and further-
more, both RyR isoforms described in primary skeletal
myotubes are implicated in the functional changes. To
separate the contributions of RyR1 and RyR3, we charac-
terized functional expression of b2a in cultured primary
myotubes from RyR1 KO, RyR3 KO, and double RyR1/
RyR3 KO mice. Interbreeding mice heterozygous of the
RyR1 KO allele and homozygous for the RyR3 KO allele
produced RyR1/RyR3 KO mice (Ikemoto et al., 1997;
Barone et al., 1998; Conklin et al., 2000). Genotypes were
screened by PCR as described in Materials and Methods.
Additional controls were performed in b1 KO myotubes
lacking the endogenous b1a variant. The two DHPR b
variants investigated, namely the heterologous rat b2a and
the homologous mouse b1a used as a reference, carried a T7
epitope tag fused to the amino terminus for determining
relative levels of protein expression in transfected cells. Fig.
1 shows confocal anti-T7 immunoﬂuorescence in four
myotube genotypes expressing the homologous and heter-
ologous DHPR b variants. The cDNA of interest was
cotransfected with the CD8 cDNA, which was used to
identify viable transfected myotubes in voltage-clamp
experiments. Dishes of transfected cells were incubated with
anti-CD8 antibody beads, ﬁxed, and processed for immu-
nostaining with anti-T7 antibody. Protein expression was
determined 4–5 days after transfection. Voltage-clamp
experiments have determined that this transfection time is
adequate for full functional recovery of EC coupling
properties in b1 KO myotubes (Beurg et al., 1997). At this
stage of protein expression, we found abundant b-protein
throughout the myotube with the exclusion of the cell nuclei.
Based on ﬂuorescence intensity, we estimated that all
myotube genotypes overexpressed exogenous b2a and b1a
proteins at comparable levels.
Transcripts for RyR3 have been detected in primary cell
cultures of WT and RyR1 KO limb myotubes (Takeshima
et al., 1995). Furthermore, functional RyR3 channels
account for caffeine-induced Ca21 release and Ca21 sparks
detected in embryonic RyR1KOmyotubes (Takeshima et al.,
1995; Conklin et al., 2000). In contrast, RyR3 has been
reported to be absent in a myogenic cell line derived from
RyR1 KO embryonic limb myotubes (Fessenden et al.,
2000). To determine whether one or two RyR variants were
present in our primary cell cultures, we conducted Ca21
release studies using caffeine and the high-afﬁnity RyR1
agonist CMC (Herrmann-Frank et al., 1996). In these
experiments, cells were loaded with ﬂuo-4 AM, and SR
Ca21 release was induced by fast perfusion of external
solution supplemented with caffeine (10 mM) or CMC (0.5
mM). The perfusion solution was passed through a large-
bore pipette placed near the cell with the pipette connected to
a pressurized manifold (ALA Scientiﬁc, Westbury, NY) and
synchronized to confocal line scan image acquisition. Fig. 2
shows Ca21 transients evoked by fast perfusion of caffeine
or CMC in WT, RyR3 KO, RyR1 KO, and RyR1/RyR3 KO
myotubes. As indicated by the line diagram above each trace
of ﬂuorescence, the external solution change lasted 4 s and
was initiated 800 ms after the start of the line scan. After the
pulse of agonist, line scan acquisition was continued for an
additional 26 s. The time course of the space-averaged
confocal ﬂuorescence intensity was computed from the line
scan image and is shown in DF/F units. A rapid increase in
myotube ﬂuorescence was observed in response to caffeine
in WT and RyR3 KO myotubes. Comparatively weaker and
slower responses to caffeine were present in ;60% of the
tested RyR1 KO myotubes (26 of 41 cells) with the rest
entirely unresponsive to caffeine. Caffeine had no effect in
double RyR1/RyR3 KO myotubes (14 of 14 cells). The
presence of caffeine-sensitive Ca21 pools in RyR1 KO and
RyR3 KO, but not in RyR1/RyR3 KO myotubes, conﬁrmed
the presence of these two RyR isoforms in our cell cultures
and was consistent with previous studies (Takeshima et al.,
1995; Conklin et al., 2000). However, since the response to
caffeine in RyR1 KO myotubes was heterogeneous,
functional RyR3 channels may not be present in all RyR1-
deﬁcient cells. Alternatively, RyR3 channels may not be
responsive to caffeine in all cells for some unknown reason.
Fig. 2 also shows that large and fast responses to CMC were
observed in WT and RyR3 KO myotubes, and much weaker
TABLE 1 Parameters of the Ca21 conductance expressed by
DHPR b1a and b2a in skeletal myotubes
Gmax (pS/pF) V1/2 (mV) k (mV)
WT 186 6 13 (28) 12 6 2 5.6 6 0.3
b1 KO 1 b1a 195 6 23 (10) 15 6 2 4.5 6 0.6
RyR3 KO 1 b1a 162 6 15 (9) 17 6 2 4.4 6 0.6
RyR1 KO 1 b1a 26 6 6* (4) 18 6 3 7.2 6 1.1
RyR1/RyR3 KO 1 b1a 36 6 10* (3) 27 6 1 5.7 6 1.1
b1 KO 1 b2a 184 6 36 (6) 11 6 1 5.1 6 0.3
RyR3 KO 1 b2a 156 6 21 (6) 11 6 2 3.8 6 0.4
RyR1 KO 1 b2a 189 6 19 (13) 12 6 2 5.1 6 0.2
RyR1/RyR3 KO 1 b2a 158 6 23 (10) 13 6 4 5.6 6 0.3
Entries correspond to the mean6 SE of Boltzmann parameters (Gmax, V1/2,
and k) ﬁtted to each cell, according to Eq. 1. The number of cells is in
parentheses. For statistical analysis, parameters of WT, all b1a-transfected
and all b2a-transfected genotypes were compared to b1a-transfected b1
KO myotubes. Asterisks indicate data in each column with 1-way ANOVA
signiﬁcance p\ 0.05.
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and slower responses were present in RyR1 KO and double
RyR1/RyR3 KO myotubes. The results in RyR3 KO
compared to RyR1 KO myotubes agreed with previous
determinations showing that CMC is predominantly a RyR1
agonist (Fessenden et al., 2000). Yet, the presence of a small
but consistent response to CMC in double RyR1 KO/ RyR3
KO myotubes (15 of 15 cells) implicates targets other than
RyRs, at least in myotubes in which both RyR isoforms are
absent. Histograms of the mean maximal ﬂuorescence
induced by caffeine and CMC and the time to maximal
ﬂuorescence after agonist exposure are shown at the bottom
of Fig. 2. Asterisks indicate ANOVA signiﬁcance p\ 0.05
relative to WT. The absence of a response to caffeine in
double KO myotubes provided a null background against
which the responses in RyR1 KO and RyR3 KO myotubes
could be compared. We observed a higher peak and faster
time-to-peak responses to caffeine in RyR3 KO than in
RyR1 KO myotubes, relative to the null background. This
suggested that RyR3 KO cells had a higher sensitivity to
caffeine than RyR1 KO cells. Alternatively, RyR3 KO cells
expressed a higher density of RyR1 receptors than the
density of RyR3 receptors expressed in RyR1 KO cells.
Since 10 mM caffeine was reported to saturate responses in
myotubes expressing either RyR1 or RyR3 (Fessenden et al.,
2000), it is likely that the differential sensitivity to caffeine
reﬂects differences in the functional density of RyRs with
RyR1 present at a much higher density than RyR3, re-
spectively, in RyR3 KO and RyR1 KO myotubes. It is also
possible that RyR1 expression may be up-regulated in RyR3
KO myotubes relative to WT since CMC responses were
signiﬁcantly higher in the former than the latter. In sum-
mary, the Ca21 release responses to caffeine and CMC show
that functional RyR1 and RyR3 are present, respectively, in
RyR3 KO and most RyR1 KO cultured myotubes.
Fig. 3 shows Ca21 conductance versus voltage relation-
ships in myotubes transfected with each of the two DHPR b
isoforms (b1a and b2a in top and bottom rows, respectively)
in each of four genotypes (b1 KO, RyR3 KO, RyR1 KO, and
RyR1/RyR3 KO in columns from left to right). b2a-trans-
fected myotubes were compared to b1a-transfected myo-
tubes even though both RyR KO genotypes are likely to
express a native DHPR that includes b1a. We felt that in the
case of the RyR KO genotypes, myotubes with exogenous
b1a overexpression provided a better control than non-
transfected myotubes since overexpression eliminated po-
tential phenotypic changes introduced by an unknown up- or
down-regulation of endogenous b1a. However, this concern
was largely unfounded. The insets show whole-cell Ca21
currents elicited by 500-ms depolarizations to 10 and 130
mV from a holding potential of40 mV. The complete pulse
protocol utilized for ﬁtting conductance versus voltage
curves consisted of 500-ms step depolarizations from 35
mV to 160 mV every 5 mV. The gray lines in each plot
indicate the mean conductance of nontransfected myotubes.
We found that nontransfected b1 KO myotubes had
marginally detectable Ca21 currents in agreement with
previous studies (Ahern et al., 2003). In b1a-expressing b1
KO myotubes, we consistently detected a high-density Ca21
current with a maximal conductance, Gmax, and other
Boltzmann parameters, similar to those of WT myotubes
(Table 1). Thus, as shown previously (Beurg et al., 1997),
b1a overexpression in the b1 KO myotube recovered the
normal Ca21 current phenotype. Furthermore, the Ca21
current density of WT myotubes was similar to that reported
previously by others and us (Beurg et al., 1997; Strube et al.,
1998; Avila and Dirksen, 2000). Averages of Boltzmann
parameters ﬁtted to the conductance versus voltage curve of
each cell and the statistical signiﬁcance of the data are shown
FIGURE 1 b-protein expression in b1 KO and RyR KO
myotubes. Confocal immunoﬂuorescence of myotubes
expressing T7-tagged DHPR b1a- or b2a-subunits. Cells
with the indicated genotype were transfected with CD8
cDNA plus the b1a or b2a cDNA. b1a corresponds to the
full-length mouse cDNA; b2a corresponds to the full-
length rat cDNA. Cells were incubated with CD8 antibody
beads, ﬁxed, and stained with anti-T7 primary/ﬂuorescein-
conjugated secondary antibodies. Pixel intensity was
converted to a 16-level inverted gray scale with high-
intensity pixels in black color. Images are 843 56 microns
and on-focus beads are 4.5 microns in diameter. The
asterisk indicates a nontransfected myotube in the same
focal plane as the transfected cell.
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in Table 1. Overexpression of b1a in the RyR3 KO myotube
did not increase Ca21 current density beyond that present in
nontransfected RyR3 KO myotubes, which was entirely
normal (Gmax ¼ 182 6 15 pS/pF, n ¼ 4 cells versus 162 6
15 pS/pF, n¼ 9 cells for nontransfected and b1a-transfected,
respectively). In RyR1 KO and RyR1/RyR3 KO myotubes,
the endogenous Ca21 current density was severely de-
pressed, and b1a overexpression failed to increase it beyond
levels present in nontransfected cells. The Gmax of non-
transfected RyR1 KO and RyR1/RyR3 KO myotubes were
27 6 5 pS/pF (14 cells) and 24 6 10 pS/pF (4 cells),
respectively. These values were statistically similar to the
density of b1a-transfected RyR1 KO and RyR1 KO/RyR3
KO myotubes shown in Table 1. The inability of exogenous
b1a overexpression to increase the Ca21 current density in
RyR1-deﬁcient myotubes was not surprising in light of the
known fact that RyR1 is a strong enhancer of the native
DHPR Ca21 current (Nakai et al., 1996; Avila et al., 2001;
Ahern et al., 2003). Thus, absence of RyR1, and not the
endogenous level of the DHPR b1a-subunit, may be the
limiting factor for Ca21 current expression in the RyR1-
deﬁcient genotypes. In b1 KO myotubes, b2a expressed
a high-density Ca21 current with a Gmax similar to that
recovered by b1a (Table 1). Moreover, the half-activation
potential and voltage dependence of the Ca21 current
expressed by the b1a and b2a were also similar. Also,
previous studies had shown that Ca21 currents recovered by
b1a and b2a had similar mean-variance noise characteristics
and activation kinetics (Beurg et al., 1999b). Hence it is
highly likely that b2a became integrated into a functional
skeletal DHPR with the pore subunit a1S providing the
pathway for the Ca21 current. The fate of the two other
subunits of the DHPR in this hybrid complex is not known.
However, their presence in the complex is suggested by the
complete normalcy of the Boltzmann parameters of the Ca21
conductance recovered by b2a (Table 1). b2a overexpres-
sion in RyR1 KO myotubes was recently shown to restore
a slow Ca21 current with an entirely WT density (Ahern
et al., 2003). The bottom row of Fig. 3 conﬁrmed this
observation and further showed that b2a recovered high-
density Ca21 currents in all genotypes analyzed, including
double RyR1/RyR3 KO myotubes. In the RyR1 KO and
RyR1 KO/RyR3 KO myotubes, b2a recovered Ca21
currents with a density ;5 fold larger than that present in
nontransfected cells and similar to that of WT myotubes
(Table 1). Thus, in contrast to the behavior of b1a, Ca21
currents recovered by b2a readily bypassed the inhibition
imposed by the absence of RyR1. Furthermore, the results in
double KO myotubes showed that neither RyR1 nor RyR3
were required for DHPR Ca21 current expression when
the heterologous b2a-subunit was present in the DHPR
complex. Given this drastic change in Ca21 current ex-
pression pattern, we further tested if b2a was capable of
recruiting a pore subunit other than a1S which could
potentially be present in the cultured myotube and that could
account for the Ca21 currents recovered by b2a. Controls
indicated that neither b1a nor b2a recovered Ca21 currents
when overexpressed in a1S-null dysgenic myotubes in
similar cell culture conditions (not shown). Thus, non-a1S
pore subunits, if present in skeletal myotubes, may not be
able to combine with b1a or b2a to generate functional Ca21
channels. This result strongly suggested that Ca21 currents
FIGURE 2 SR Ca21 release induced by caffeine and
CMC in WT and RyR KO myotubes. Time course of
confocal ﬂuo-4 ﬂuorescence is shown for nontransfected
myotubes of the indicated genotype: normal (WT), RyR3
KO, RyR1 KO, and double RyR1/RyR3 KO. Different
cells were used to elicit responses to caffeine (top row) and
CMC (bottom row). The line diagrams indicate rapid
perfusion for 4 s of external solution with 10 mM caffeine
or 0.5 mM CMC with a total line scan duration (x axis) of
30.8 s. Traces show the time course of the spatial integral
of the line scan image ﬂuorescence in DF/F units. Note
differences in DF/F scales. Histograms show Ca21 release
responses to caffeine (left) and CMC (right). The maximal
confocal ﬂuorescence in DF/F units (mean6 SE) is shown
after myotube exposure to 10 mM caffeine (left) or 0.5 mM
CMC (right). The time to maximal ﬂuorescence (mean 6
SE) is shown within a 30.8-s line scan after agonist
perfusion. The numbers in parentheses indicate the number
of tested cells. None of the tested RyR1/RyR3 KO
myotubes (n ¼ 14) responded to caffeine; 26 of 41
RyR1 KO myotubes tested responded to caffeine, and
statistics are provided for caffeine-sensitive cells; all WT
and RyR3 KO myotubes tested responded to caffeine and
CMC; and all RyR1 KO and RyR1/RyR3 KO myotubes
tested responded to CMC. Asterisks indicate statistical
signiﬁcance p\ 0.01 in one-way ANOVA against WT.
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recovered by b2a in RyR1 KO and RyR1/RyR3 KO
myotubes originated from hybrid DHPR complexes that
included a1S and the exogenous b2a-subunit. A mechanism
explaining how Ca21 currents recovered by b2a bypass the
requirement for RyR1 has been proposed elsewhere (Ahern
et al., 2003).
In b1 KO myotubes overexpressing b1a, the Ca21 current
has no bearing on the magnitude of the Ca21 transient
(Beurg et al., 1997). However, recent studies showed that
long depolarizations signiﬁcantly increased the total Ca21
entering the cell, and that the excess of Ca21 entry triggered
SR Ca21 release when b1 KO myotubes overexpressed
truncated variants of b1a (Sheridan et al., 2003a). For this
reason, possible changes in EC coupling produced by b2a
overexpression were tested by voltage steps with a duration
of 50 ms and 200 ms in the range of 30 mV to 190 mV,
which covered both the inward and outward phases of
the myotube Ca21 current. Fig. 4 shows confocal Ca21
transients in response to 200-ms depolarizations to 130 and
190 mV from a holding potential of 40 mV in the same
myotube. Ca21 currents were acquired concurrently, and
they were similar in density to those described in Fig. 3. The
entire pulse protocol consisted of 50-ms and 200-ms
depolarizations, and a comparison of Ca21 transients
stimulated by the two protocols is described below. Because
the Ca21 current becomes progressively smaller at potentials
[30 mV, as the imposed voltage approaches the Ca21
current reversal potential and the Ca21 equilibrium potential,
a contribution of the Ca21 current as trigger of the Ca21
transient can be readily deduced by comparing Ca21
transients at 130 mV and 190 mV. Fig. 4 shows that in
b1 KO cells overexpressing b1a, Ca21 transients had
a nearly identical shape and magnitude at 130 and 190
mV. This result was consistent with the previous data (Beurg
et al., 1999a,b; Sheridan et al., 2003a) and the well-known
voltage dependence of skeletal-type EC coupling, which is
unrelated to the fate of the Ca21 current (Rios and Pizarro,
1991). Similarly, Ca21 transients in b1a-expressing RyR3
KO myotubes had the same maximal intensity at 130 and
190 mV, and this result agreed with previous determinations
showing that RyR3 KO myotubes display skeletal-type EC
coupling (Dietze et al., 1998). In myotubes lacking RyR1
(RyR1 KO and RyR1/RyR3 KO), b1a overexpression failed
to recover Ca21 transients, which is not surprising since
RyR3 is incapable of supporting skeletal-type EC coupling
(Fessenden et al., 2000). Additionally, the Ca21 current
density in the RyR1-deﬁcient genotypes is noticeably small.
Hence, Ca21-dependent Ca21 release or a direct contribution
of the Ca21 current to the cell ﬂuorescence would be difﬁcult
to detect in these cells. In contrast, Ca21 transients of various
magnitudes were detected in all myotube genotypes over-
expressing b2a and were two- to ﬁvefold smaller at 190
than at130 mV (Fig. 4, bottom row). Furthermore, in RyR1
KO and RyR1/RyR3 KO myotubes, b2a-mediated Ca21
transients were seen at 130 but not at 190 mV, suggesting
that a signiﬁcant proportion of the ﬂuorescence signal in
these myotubes could arise from the Ca21 current itself. b2a-
mediated Ca21 transients in b1 KO myotubes were smaller
in magnitude than those in b1a-expressing b1 KO, in
agreement with previous determinations (Beurg et al.,
1999b). In addition, the selected b2a-expressing RyR3 KO
myotube shows Ca21 transients larger than that of the b2a-
expressing b1 KO myotube. However, on average, this
difference was not signiﬁcant (Table 2). The results in b1
KO and RyR3 KO myotubes suggested that b2a expression
changed the EC coupling signal from one that is controlled
by voltage to one in which the Ca21 current served as
a trigger. We were especially surprised by the changes in the
voltage dependence of Ca21 transients in RyR3 KO
myotubes since nontransfected RyR3 KO myotubes (Dietze
et al., 1998) or b1a-overexpressing RyR3 KO myotubes
(Fig. 4, top row) showed bona ﬁde skeletal-type EC
FIGURE 3 Ca21 conductance expressed by the heter-
ologous DHPR b2a-subunit in b1 KO and RyR KO
myotubes. Myotubes with the indicated genotype (b1 KO,
RyR3 KO, RyR1 KO, and double RyR1/RyR3 KO) were
transfected with b1a (top row) or b2a (bottom row). Insets
show representative Ca21 currents at 10 mV and 130
mV for a depolarization of 500 ms from a holding potential
of 40 mV. Lines correspond to a Boltzmann ﬁt of the
population mean Ca21 conductance indicated in Table 1.
All conductance versus voltage curves were ﬁt with Eq. 1.
Parameters of the ﬁtted lines, with Gmax in pS/pF, V1/2 in
mV, and k in mV, were as follows: for b1 KO myotubes,
were 194, 14.9, and 7 for b1a overexpression and 183,
11.6, and 5.2 for b2a overexpression; for RyR3 KO
myotubes, were 162, 15.5, 6.1 for b1a and 156, 10.5, 5 for
b2a; for RyR1 KO myotubes were 25, 17.9, 6.6 for b1a
and 184, 13.2, 6.4 for b2a; for RyR1/RyR3 KO myotubes
were 35, 25.8, 5.8 for b1a and 157, 14.6, 8 for b2a.
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coupling. This result seemed to indicate that b2a behaved as
a negative dominant subunit capable of disrupting normal
DHPR function in the RyR3 KO myotube.
To determine how much of the ﬂuorescence signal in b2a-
expressing myotubes was due to the Ca21 current and how
much was due to SR Ca21 release, we examined ﬂuo-
rescence versus voltage and Ca21 current versus voltage re-
lationships acquired concurrently. Fluorescence signals in
RyR1/RyR3 KO myotubes should exclusively reﬂect the
contribution of the Ca21 current, whereas those in RyR1 KO
should reﬂect the contribution of the Ca21 current and Ca21
entry dependent Ca21 release mediated by RyR3. Consistent
with this idea, Fig. 5 A shows that b2a-mediated Ca21
transients in RyR1 KO (closed circles) and RyR1 KO/RyR3
KO (closed squares) myotubes had a bell-shaped depen-
dence with a maximum at 130 mV, which coincided with
the maximal Ca21 current shown in Fig. 5 B. Additionally,
the peak DF/F at 130 mV was larger in RyR1 KO than in
RyR1 KO/RyR3 KO myotubes, whereas the Ca21 current
density was similar in both cases. The baseline for these
curves was provided by the behavior of nontransfected RyR1
KO myotubes (open circles) and RyR1/RyR3 KO myotubes
(open squares), which lacked Ca21 transients entirely and
expressed a minimal Ca21 current. The peak DF/F of
nontransfected myotubes was undistinguishable from the
noise of the measurement, which was ;0.1 DF/F (see
Materials and Methods). We surmise that the excess in cell
ﬂuorescence in b2a-expressing RyR1 KO myotubes, above
that present in b2a-expressing RyR1 KO/RyR3 KO
myotubes, should reﬂect SR Ca21 release due to Ca21-
dependent activation of RyR3. To conﬁrm this idea, b2a-
expressing RyR1 KO myotubes were treated with 5 mM
ryanodine to block any RyR-dependent SR Ca21 release.
Fig. 5 C shows representative Ca21 transients and Ca21
currents at130 mV in a b2a-expressing RyR1 KO myotube
(black traces) and in a separate b2a-expressing RyR1 KO
myotube treated with ryanodine (gray traces). To ensure
a complete elimination of the ﬂuorescence change due to EC
coupling, myotubes were exposed to ryanodine for 30 min.
For this reason, controls and ryanodine-treated cells were
different. Myotubes were selected so that the Ca21 current
densities were approximately the same. Ryanodine treatment
signiﬁcantly reduced the ﬂuorescence signal in b2a-express-
ing RyR1 KO myotubes and suggested that a signiﬁcant
TABLE 2 Parameters of Ca21 transients expressed by DHPR b1a and b2a in skeletal myotubes
50 ms 200 ms
DF/Fmax V1/2(mV) k(mV)
DF=FðexpmaxÞ
DF=F1 90mV DF/Fmax V1/2(mV) k(mV)
DF=FðexpmaxÞ
DF=F1 90mV
WT 2.6 6 0.4 (12) 4 6 3 8.4 6 1.0 1.1 6 0.1 2.8 6 0.4 (9) 8 6 3 9.3 6 2.1 1.1 6 0.1
b1 KO 1 b1a 2.7 6 0.5 (10) 3 6 2 7.7 6 0.5 1.0 6 0.1 3.4 6 0.6 (10) 8 6 2 5.8 6 1.1 1.2 6 0.1
RyR3 KO 1 b1a 2.2 6 0.4 (10) 6 6 2 8.6 6 1.1 1.2 6 0.1 3.3 6 0.6 (9) 9 6 2 7.2 6 1.4 1.2 6 0.1
RyR1 KO 1 b1a – (5) – – – – (7) – – –
RyR1/RyR3KO 1 b1a – (4) – – – – (5) – – –
b1 KO 1 b2a 0.9 6 0.2* (10) 2 6 3 7.4 6 1.5 1.5 6 0.1* 1.7 6 0.4* (10) 6 6 3 7.6 6 1.9 2.3 6 0.4*
RyR3 KO 1 b2a 0.6 6 0.1* (8) 8 6 4 9.4 6 1.3 1.2 6 0.1 1.9 6 0.3* (14) 4 6 3 7.1 6 0.9 1.3 6 0.1
RyR1 KO 1 b2a – (5) – – – 0.4 6 0.1* (5) 6 6 2 6.3 6 1.0 4.5 6 0.9*
RyR1/RyR3KO 1 b2a – (3) – – – 0.2 6 0.1* (7) 12 6 4 9.2 6 0.4 2.6 6 0.4*
Mean 6 SE of Boltzmann parameters ﬁtted to each cell with number of cells in parentheses. DF/Fmax, V1/2, and k are parameters of the Boltzmann ﬁt.
Parameters of ﬂuorescence versus voltage curves are shown for 50-ms and 200-ms depolarizations. All data from b1a-expressing myotubes and 50-ms data
from myotubes expressing b2a were ﬁt with Eq. 1. The 200-ms data from myotubes expressing b2a was ﬁt with Eq. 2. DF/F (exp max) corresponds to the
experimental maximal DF/F for a given ﬂuorescence versus voltage curve. DF/F 190 mV corresponds to the experimental DF/F at 190 mV. For statistical
analysis, parameters of WT, all b1a-transfected, and all b2a-transfected genotypes were compared to b1a-transfected b1 KO myotubes. Asterisks indicate
data in each column with 1-way ANOVA signiﬁcance p\ 0.05.
FIGURE 4 Ca21 transients expressed by the heterolo-
gous DHPR b2a-subunit in b1 KO and RyR KO
myotubes. Myotubes with the indicated genotype (b1
KO, RyR3 KO, RyR1 KO, and double RyR1/RyR3 KO)
were transfected with b1a (top row) or b2a (bottom row).
Ca21 transients were elicited by step depolarizations to
130 and 190 mV. Myotubes were held at a resting
potential of40 mV and depolarized for 200 ms. The time
course of the cell ﬂuorescence was obtained by integration
of the line scan image as described in Materials and
Methods. Note differences in DF/F scales.
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component of the ﬂuorescence signal in b2a-expressing
RyR1 KO myotubes was due to RyR-dependent SR Ca21
release presumably mediated by RyR3. Since Ca21 current
densities in all b2a-expressing genotypes were roughly
similar (Table 1), we estimated the relative magnitude of the
b2a-mediated Ca21 release in all genotypes by normalizing
the peak DF/F relative to the magnitude of the Ca21 current
at the same potential of 130 mV (Fig. 5 D). The normalized
signal in RyR1/RyR3 KO myotubes represents the direct
contribution of the Ca21 current to the cell ﬂuorescence, and
progressively larger signals due to SR Ca21 release were
present in RyR1 KO, RyR3 KO, and b1 KO myotubes. The
largest Ca21 release signals were observed in the RyR1-
expressing myotubes (b1 KO and RyR3 KO) consistent with
the idea that RyR1 is expressed at a much higher density than
RyR3 described above. Voltage-dependent components in
b2a-transfected RyR3 KO and b1 KO myotubes also
contributed to the ﬂuorescence signal in these cells and
are discussed separately (see Figs. 6 and 9). The cell
ﬂuorescence to Ca21 current ratio at 130 mV was not
statistically different for b2a-transfected RyR3 KO and b1
KO myotubes. However, this ratio was signiﬁcantly smaller
for b2a-transfected RyR1 KO and RyR1/RyR3 KO
myotubes (t-test signiﬁcance p\ 0.05) and is indicated by
asterisks. The main conclusions from the comparison in Fig.
5 D are that the Ca21 current has a modest impact on the
measured myotube ﬂuorescence and that both RyR isoforms
(RyR1 and RyR3), when present, can be activated by the
Ca21 current recovered by b2a overexpression.
Ca21 release triggered by the Ca21 current follows the
voltage dependence of the Ca21 current. Hence, this EC
coupling mechanism can be distinguished from purely
voltage-dependent EC coupling by the shape of the Ca21
ﬂuorescence versus voltage relationship. Additionally,
Ca21-dependent EC coupling should be a sensitive function
of the duration of the depolarizing stimulus as longer
depolarizations increase the amount of trigger Ca21 entering
the cell. Previous studies showed that depolarizations for 50
ms were adequate for activation of DHPR charge movements
(Ahern et al., 2003). However, activation of the Ca21 current
to near steady state required depolarizations of 200 ms
(Sheridan et al., 2003a). For these reasons, we investigated
the shape of ﬂuorescence versus voltage curves for depo-
larizations of 50 and 200 ms in the same cell. Fluores-
cence versus voltage relationships are shown in Fig. 6 for
b1a and b2a overexpression in the four myotube geno-
types under investigation. The DF/F value reached at the
end of the depolarization was plotted as a function of
voltage for depolarizations of 50 ms (closed symbols) and
200 ms (empty symbols). The gray traces indicate the mean
ﬂuorescence of nontransfected myotubes. The duration of
the pulse did not affect the sigmoidal voltage dependence of
Ca21 transients expressed by b1a in b1 KO myotubes,
which is in agreement with recent observation from our
laboratory (Sheridan et al., 2003a) and studies in adult
skeletal muscle (Melzer et al., 1986). Interestingly, RyR3
KO myotubes overexpressing b1a had sigmoidal ﬂuo-
rescence versus voltage curves with a higher maximal
FIGURE 5 Contribution of the Ca21 current and RyR3
to the cytosolic ﬂuorescence determined in RyR1 KO
myotubes. Panels A and B show the maximal confocal
Ca21 ﬂuorescence (A) and peak Ca21 current (B) for
nontransfected and b2a-transfected RyR1 KO and RyR1/
RyR3 KO myotubes. Cells were depolarized for 200 ms
from a holding potential of 40 mV. The mean 6 SE
maximal DF/F and Ca21 current are plotted for ﬁve
nontransfected RyR1 KO myotubes (open circles); 7
RyR1 KO myotubes overexpressing b2a (closed circles);
3 nontransfected RyR1/RyR3 KO myotubes (open
squares); and 7 RyR1/RyR3 KOmyotubes overexpressing
b2a (closed squares). The maximal Ca21 ﬂuorescence
during the Ca21 transients was obtained from the inte-
grated confocal line scan image as described in Materials
and Methods. Panel C shows Ca21 transients and Ca21
currents at 130 mV in an RyR1 KO myotube over-
expressing b2a in external solution (control; black traces)
and external solution supplemented with ﬁve mM
ryanodine (gray traces). The pulse duration was 200 ms
and the holding potential was 40 mV. The digitized
traces show ﬂuo-4 ﬂuorescence in DF/F units obtained
during the confocal line scan. Each dot corresponds to the
mean ﬂuorescence of a single 512-pixel line acquired at
a rate of 2.05 ms per line. Ca21 currents acquired concurrently are shown below traces of ﬂuorescence. Panel D shows the maximal ﬂuorescence in DF/F units
during a 200-ms stimulus divided by the maximal Ca21 current in the same myotube acquired concurrently. Entries correspond to the mean 6 SE for b2a-
expressing b1 KO (0.416 0.11, n¼ 10 cells), RyR3 KO (0.296 0.05, n¼ 14 cells), RyR1 KO (0.086 0.02, n¼5 cells), and RyR1/RyR3 KO (0.056 0.01,
n ¼ 7 cells) myotubes.
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ﬂuorescence (DF/Fmax) for the 200 ms than for the 50 ms
stimulation. This difference was also observed in non-
transfected myotubes (DF/Fmax ¼ 1.8 6 0.1 for 50 ms and
2.7 6 0.1 for 200 ms for four cells) and is shown by the two
gray traces in the top and bottom graphs corresponding to
RyR3 KO myotubes. However, the differences in DF/Fmax
for 50-ms and 200-ms depolarizations were not signiﬁcant
either in b1a-transfected (see Table 2) or nontransfected
RyR3 KO myotubes. A contribution of RyR3 to the overall
rate of propagation of Ca21 release has been previously
reported in cultured RyR3 KO myotubes and could underlie
the small difference in DF/Fmax observed here for the short
and long depolarizations (Yang et al., 2001). In RyR1 KO
and RyR1/RyR3 KO myotubes, b1a overexpression failed
to recover Ca21 transients entirely, in agreement with the
critical role of RyR1 in voltage-dependent coupling and the
absence of b1a stimulated Ca21 current expression in these
genotypes. b2a overexpression changed the shape of the
ﬂuorescence versus voltage curve in the RyR1-expressing
genotypes (b1 KO and RyR3 KO) and introduced Ca21
transients in the RyR1-deﬁcient genotypes (RyR1KO and
RyR1/RyR3 KO) that were not present in nontransfected
counterparts. In b1 KO and RyR3 KO myotubes, b2a-
overexpression reduced the DF/Fmax produced by the 50-ms
stimulation relative to that recovered by b1a, and further-
more, the ﬂuorescence versus voltage curves generated with
the 200-ms pulse were clearly bell-shaped. Bell-shaped
curves were also observed for the 200-ms depolarization in
RyR1 KO and RyR1/RyR3 KO myotubes but not for the 50-
ms depolarization. In all cases, the 200-ms depolarization
produced an increase in ﬂuorescence in the range of30 mV
to 120 mV, a maximum at ;130 mV, and a decline in
ﬂuorescence in the range of 140 mV to 190 mV. To
quantify these observations, we ﬁtted the curves obtained
with the 200-ms depolarization for b2a-expressing myotubes
with a modiﬁed Boltzmann equation that takes into account
the reversal potential of the Ca21 current (Eq. 2), whereas the
rest of the curves in Fig. 6 were ﬁt with a conventional
Boltzmann equation (Eq. 1). The degree of curvature of the
ﬂuorescence versus voltage plots at positive potentials was
estimated by computing the ratio of ﬂuorescence at the
experimental maximum (exp max) for a given ﬂuorescence
versus voltage curve (typically 130mV) and the ﬂuores-
cence at 190 mV ð½DF=F expmax=½DF=F190mVÞ. The
Boltzmann parameters of the ﬁt of each cell and the
ﬂuorescence ratios at 50 ms and 200 ms are shown in Table
2 along with the statistical signiﬁcance and the number of
cells. In summary, a dependence of the Ca21 transient
amplitude on pulse duration was observed for b2a-over-
expressing myotubes. This was reﬂected in the bell-shaped
ﬂuorescence versus voltage relationships, consistent with the
presence of an EC coupling component triggered by the
Ca21 current in all myotube genotypes overexpressing b2a.
Ca21 transients were the smallest in RyR1/RyR3 KO
myotubes, and, as mentioned previously, they reﬂected the
ﬂuorescence contributed by the Ca21 current itself.
If the Ca21 current triggered SR Ca21 release in myotubes
expressing b2a, the rate of rise of the ﬂuorescence signal and
the rate of Ca21 entering the cell should have a similar time
course. Fig. 7 shows Ca21 transients and Ca21 currents
produced by a 200-ms depolarization to 130 mV from
a holding potential of 40 mV in the four myotube
genotypes. To correlate the time course of the Ca21 transient
and the Ca21 current, we compared the cumulative sum of
the Ca21 entry charge during the depolarization (i.e., the
running integral of the Ca21 current) with the ﬂuorescence
FIGURE 6 Sigmoidal and bell-shaped voltage depen-
dence of Ca21 transients in myotubes expressing the
heterologous DHPR b2a-subunit. Ca21 transients in DF/F
units were measured in myotubes with the indicated
phenotype (b1 KO, RyR3 KO, RyR1 KO and double
RyR1/RyR3 KO) expressing b1a (top row) or b2a (bottom
row). The depolarization duration was 50 ms (closed
symbols) or 200 ms (open symbols) from a holding
potential of 40 mV. The same myotube was subjected to
the 50-ms and 200-ms depolarization protocols. Ca21
transients were measured at the end of each depolarization
from the time course of the integrated confocal line scan
image ﬂuorescence. The lines correspond to a Boltzmann
ﬁt of the population mean DF/F indicated in Table 2. All
ﬂuorescence vs. voltage curves were ﬁt with Eq. 1 except
those obtained with the 200 ms depolarization in myotubes
overexpressing b2a, which were ﬁt with Eq. 2. Parameters
of the ﬁtted lines (DF/Fmax inDF/F units, V1/2 in mV, and
k in mV) for b1 KO overexpressing b1a are: 2.8,6.1, 7.8
for 50 ms and 3.2, 10.2, 5.7 for 200 ms. Parameters for
b1 KO overexpressing b2a are: 0.8,2.5, 5.8 for 50 ms and 1.8, 9, 9.7 for 200 ms. Parameters for RyR3 KO overexpressing b1a are: 2.2,7.2, 8.2 for 50 ms
and 3.2,9.9, 7.3 for 200 ms. Parameters for RyR3 KO overexpressing b2a are: 0.6, 8.5, 11.3 for 50 ms and 1.5, 3.6, 10 for 200 ms. Parameters for RyR1 KO
overexpressing b2a are: 0.4, 9.8, 8.9 for 200 ms. Parameters for RyR1/RyR3 KO overexpressing b2a are: 0.2, 7.9, 10 for 200 ms.
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signal. We have previously argued that this is a fair
comparison because Ca21 ﬂuorescence was measured in
an internal solution containing a low EGTA concentration
(0.1 mM), and, thus, the cell ﬂuorescence tracked Ca21
accumulation rather than the rate of SR Ca21 release
(Sheridan et al., 2003a,b). Accordingly, the confocal
ﬂuorescence every 2.05 ms (gray dots in DF/F units), and
the running integral of the Ca21 current (smooth curve in
black in units of pA 3 ms) were superimposed. For the
RyR1-expressing myotubes (b1 KO and RyR3 KO) with
b1a-overexpression, the ﬂuorescence signal increased ear-
lier and faster than the Ca21 charge. Furthermore, the
ﬂuorescence signal saturated before termination of the
200-ms pulse, whereas the Ca21 charge continued to increase
for as long as the pulse was at 130 mV. In contrast, Ca21
transients obtained by b2a-overexpression were consider-
ably slower than those obtained by b1a-overexpression.
Furthermore, there was a much closer agreement in the
kinetics of the two signals in myotubes overexpressing b2a,
which was particularly compelling in the b2a-expressing
RyR1 KO myotube. In RyR1/RyR3 KO myotubes, the
ﬂuorescence signal was too noisy to permit a comparison,
and, for that reason, it was not expanded. In summary, b2a
overexpression eliminated the fast EC coupling typical of
skeletal myotubes. Furthermore, the slow EC coupling ob-
served in myotubes expressing b2a appears to have its
kinetic basis on the slow time course of the skeletal DHPR
Ca21 current.
In the RyR1-expressing b1 KO and RyR3 KO myotubes,
it could be argued that b2a induced a mixed form of EC
coupling with voltage and Ca21 serving as triggers. This is
based on the fact that a pool of native DHPRs is expected to
be present in these cells even after b2a-overexpression. In
addition, in b1 KO and RyR3 KO myotubes overexpressing
b2a, the 50-ms depolarization produced DF/F versus voltage
curves with a quasi-sigmoidal shape, whereas the 200-ms
depolarization induced relationships that were clearly bell-
shaped (Fig. 6). Thus, the brief depolarization may not have
been sufﬁcient to fully activate the slow Ca21 current but
may have been sufﬁcient to activate DHPR voltage sensors
and trigger voltage-dependent EC coupling. To demonstrate
if mixed voltage and Ca21 dependent coupling had occurred,
Ca21 transients were measured in b2a-expressing b1 KO,
RyR3 KO, and RyR1 KO myotubes before and after
inhibition of the Ca21 current with 2.5 mM nifedipine. Fig.
8 shows Ca21 currents in the same myotube in response to
a depolarization to130 mV from a holding potential of40
mV. In these experiments, we used b1a-overexpressing b1
KO myotubes as a control since this isoform fully restores
skeletal-type EC coupling (Beurg et al., 1997; Sheridan et al.,
2003a). In all cases, fast-perfusion with external solution
containing nifedipine abolished the Ca21 current to a level
below detection (gray traces), which was;20 pA/cell. Ca21
transients monitored concurrently are shown before and after
Ca21 current inhibition. In the b1 KO myotubes overex-
pressing b1a, approximately half of the Ca21 transient was
resistant to nifedipine, consistent with previous studies in
cultured skeletal myotubes (Nakai et al., 1998a; Wilkens
et al., 2001). The partial inhibitory effect of nifedipine on
skeletal-type EC coupling has been previously documented
and is presumably due to partial inhibition of DHPR charge
movements (Rios and Pizarro, 1991). Similarly, nifedipine
produced a partial block of Ca21 transients in RyR3 KO
myotubes, consistent with the idea of mixed voltage and
Ca21 dependent coupling in this genotype. In contrast,
nifedipine treatment entirely eliminated Ca21 transients in-
duced by b2a overexpression in b1 KO and RyR1 KO
myotubes. Hence, in these cells, the Ca21 current was
overwhelmingly responsible for triggering EC coupling. In
a few b2a-expressing b1 KO cells, we observed a small
nifedipine-insensitive ﬂuorescence signal, which could be
attributed to a minor component of skeletal-type EC
coupling promoted by b2a. However, this was not con-
sistently observed in all batches of transfected cells, pre-
FIGURE 7 Correlation between the rate of cytosolic
Ca21 increase and rate of Ca21 accumulation in myotubes
overexpressing the heterologous DHPR b2a-subunit. Each
panel shows Ca21 currents and Ca21 transients in
myotubes of the indicated genotype (b1 KO, RyR3 KO,
RyR1 KO, and double RyR1/RyR3 KO) overexpressing
b1a (top row) or b2a (bottom row) in response to a 200-ms
depolarization from a holding potential of –40 mV to130
mV in external solution with 10 mM Ca21. The digitized
trace (gray) shows ﬂuo-4 ﬂuorescence in DF/F units
during the confocal line scan. Each dot corresponds to the
mean ﬂuorescence of a single 512-pixel line acquired at
a rate of 2.05 ms per line. The black trace shows the
cumulative integral of the Ca21 current (running integral)
in fC (pA 3 ms) superimposed on the ﬂuorescence trace.
Actual Ca21 currents are shown below the trace of
ﬂuorescence. Note changes in DF/F units and fC units.
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sumably due to the small magnitude of the signal and the
variability in the levels of the expressed protein. In summary,
the pharmacological approach indicated that a mixed form
of EC coupling was observed in RyR3 KO myotubes.
However, the Ca21 current appeared to be more important
than voltage as EC coupling trigger in b1 KO and RyR1 KO
myotubes overexpressing b2a.
The pharmacological approach using nifedipine indicated
that b2a overexpression promoted Ca21-dependent EC
coupling. However, the loss of voltage-dependent EC coup-
ling could not be directly determined since nifedipine
partially inhibited voltage sensors. To determine the extent
to which voltage-dependent EC coupling was reduced by
b2a overexpression, we coexpressed b2a and a Ca21-
impermeant a1S pore mutant (E1014K) in a double
dysgenic/b1 KO myotube lacking WT a1S- and b1a-
subunits. Previous studies in dysgenic (a1S-null) myotubes
had shown that substitution of a critical glutamate residue at
position 1014 by lysine in the pore loop of repeat III of a1S
completely abolished inward Ca21 currents, whereas skel-
etal-type EC coupling was restored quantitatively (Dirksen
and Beam, 1999; Ahern et al., 2001b). Thus, by coexpressing
b2a and the nonconducting a1S-subunit in a null back-
ground for both subunits, we assessed voltage-dependent EC
coupling promoted directly by b2a in the absence of Ca21
current trigger. Double mutant mice lacking a1S and b1a
were obtained by interbreeding dysgenic and b1 KO mice
heterozygous for the mdg and b1 KO alleles as described in
Materials and Methods. Similar to dysgenic and b1 KO
myotubes, double dysgenic/b1 KO myotubes were pre-
viously shown to be entirely devoid of Ca21 currents and EC
coupling. Furthermore, only by coexpressing both missing
subunits in double dysgenic/b1 KO myotubes (a1S 1 b1a),
was the normal skeletal myotube phenotype restored (Ahern
et al., 1999). To form the a1S/b1a and a1S/b2a subunit
pairs, the b variant cDNAs were transfected in b1 KO
myotubes which are otherwise WT for a1S and the other
DHPR genes (Gregg et al., 1996). To form the a1S
(E1014K)/b1a pair, the mutant a1S (E1014K) cDNA was
transfected in dysgenic myotubes which are otherwise WT
for b1 and other DHPR genes (Chaudhari, 1992; Ahern et al.,
1999; Arikkath et al., 2003). Fig. 9 shows Ca21 transients
and Ca21 currents at 130 mV from a holding potential of
40 mV in response to a 200-ms depolarization in three
myotube genotypes under the same conditions. Panel A
shows a b1 KO myotube expressing b1a and separately
a dysgenic myotube expressing a1S (E1014K). Panel C
shows a b1 KO myotube expressing b2a and separately
a double dysgenic/b1 KO myotube coexpressing a1S
(E1014K) 1 b2a. Average ﬂuorescence versus voltage and
current versus voltage curves are shown in panels B and D,
respectively. At 130 mV, the maximal Ca21 current
densities were 5.4 6 0.3 pA/pF (10 cells) and 4.6 6
0.7 (10 cells) for myotubes expressing the WT a1S/b1a and
WT a1S/b2a pairs, respectively, in panels B and D. In
contrast, the pore mutant inward currents at the same
potential were below the level of detection (;0.05 pA/pF),
in agreement with previous results (Dirksen and Beam,
1999; Ahern et al., 2001b). Outward currents at potentials
more positive than 130 mV correspond to a mixture of
background currents present in the cultured myotube and
outward monovalent current through the pore mutant Ca21
channel (Yang et al., 1993).
As indicated by the average DF/F curves in Fig. 9 B, Ca21
transients of a comparable maximal magnitude and sigmoi-
dal voltage dependence were obtained in b1 KO myotubes
expressing b1a and dysgenic (labeled mdg) myotubes
expressing a1S (E1014K). Thus, expressed DHPRs carrying
either a WT or a pore-mutant a1S-subunit were capable of
restoring voltage-dependent EC coupling. This result is in
accordance with the well-known lack of involvement of the
L-type Ca21 current as EC coupling trigger in skeletal
FIGURE 8 Nifedipine-sensitive Ca21 transients ex-
pressed by the heterologous DHPR b2a-subunit in b1
KO, RyR3 KO, and RyR1 KO myotubes. From left to
right, the panels show Ca21 transients, Ca21 currents, and
ﬂuorescence versus voltage curves for b1a in b1 KO, b2a
in b1 KO, b2a in RyR3 KO, and b2a in RyR1 KO
myotubes. Myotubes were depolarized for 200 ms from
a holding potential of 40 mV to 130 mV in external
solution with 10 mM Ca21. Ca21 transients and Ca21
currents were measured in the same myotube before and
after block of the Ca21 current with 2.5 mM nifedipine.
Time course of the Ca21 transient and Ca21 current after
nifedipine inhibition is shown in gray. The time course of
the cell ﬂuorescence was obtained by integration of the
line scan image as described in Materials and Methods.
Graphs show the ﬁt of voltage dependence of the maximal
DF/F during the depolarization using Eq. 1 for b1a
overexpression or Eq. 2. for b2a overexpression. Gray
symbols show ﬂuorescence versus voltage curve after
myotube exposure to nifedipine.
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muscle and, more speciﬁcally, with the behavior of a1S
(E1014K) in previous studies in dysgenic myotubes (Dirksen
and Beam, 1999; Ahern et al., 2001b). In contrast, Ca21
transients in double dysgenic/b1 KO myotubes expressing
a1S (E1014K) and b2a in Fig. 9 D were substantially
smaller than those in b2a-expressing b1 KO myotubes.
Thus, elimination of the pore function in the a1S-sub-
unit curtailed the magnitude of the Ca21 transient when
b2a formed part of the DHPR complex. Moreover, the
ﬂuorescence versus voltage curve was bell-shaped in the
case of the WT a1S/b2a pair but sigmoidal for the a1S
(E1014K)/b2a pair, consistent with the idea that the pore
mutant DHPR contributed only to voltage-dependent EC
coupling. The bell-shaped ﬂuorescence versus voltage curve
for the WT a1S/b2a pair was in agreement with data in Fig.
6. From the magnitude of Ca21 transients in b2a-expressing
b1 KO myotubes and a1S (E1014K) 1 b2a-expressing
double dysgenic/b1 KO myotubes in Fig. 9 D, we estimated
that the voltage-dependent component of EC coupling was
;20% of the total Ca21 transient at 130 mV. From these
observations we concluded that the DHPR b2a-subunit
eliminated a sizable amount of voltage-dependent EC
coupling despite the presence of a WT a1S pore subunit.
Hence, in myotubes overexpressing b2a and lacking b1a,
Ca21 entry dominates over voltage as EC coupling trigger.
DISCUSSION
This work shows that replacement of the skeletal DHPR
b1a-subunit by the cardiac/brain variant b2a, in the context
of a WT a1S pore subunit, modiﬁes the EC coupling signal
from one controlled by voltage to one controlled by the Ca21
current. The changes in EC coupling were most pronounced
in b1 KO myotubes and, by comparison to b1a, b2a
produced an overall decrease in the amplitude of Ca21
transients with evident changes in the shape of the Ca21
ﬂuorescence versus voltage relationship, slowing of the
kinetics of the Ca21 transient, and a dependence of Ca21
transients on the Ca21 current. These observations, the
pharmacological interventions using nifedipine, and the
results in double dysgenic/b1 KO myotubes are all con-
sistent with a loss in voltage-dependent EC coupling and
emergence of Ca21-dependent EC coupling triggered by the
slow L-type DHPR Ca21 current. Partial changes in the
same direction were also observed when b2a was overex-
pressed in the presence of a native skeletal DHPR, such as in
RyR3 KOmyotubes. In this case, b2a appeared to have acted
as a negative dominant which is presumably due to the
inability of the functional hybrid DHPR composed of
skeletal subunits and b2a to fully engage in skeletal-type
EC coupling. Overall, the changes promoted by the b2a-
subunit are mechanistically important since, until this work,
only cardiac/brain DHPR a1 pore subunits (Garcia et al.,
1994; Nakai et al., 1998a), were known to introduce Ca21-
dependent EC coupling in skeletal myotubes.
By comparing DF/Fmax for the a1S (E1014K)/b1a and
a1S (E1014K)/b2a subunit pairs we can roughly estimate
the loss in skeletal-type EC coupling when b1a is replaced
by b2a in the DHPR complex. DF/Fmax was 4 6 0.6 (5
cells) and 0.3 6 0.1 (8 cells), respectively. Hence, voltage
FIGURE 9 Ca21 transients and Ca21 currents expressed
by the heterologous DHPR b2a-subunit in a1S/b1-null
myotubes. Ca21 transients and Ca21 currents in the same
myotube at 130 mV from a holding potential of 40 mV
in response to a 200-ms depolarization. Panel A shows a b1
KO myotube transfected with b1a (black traces) and
a dysgenic myotube (labeled mdg) transfected with a1S
(E1014K) (gray traces). Panel B shows average ﬂuores-
cence versus voltage and current versus voltage curves for
b1 KO myotubes expressing b1a (black traces) and
dysgenic myotubes expressing a1S (E1014K) (gray
traces). Fluorescence and whole cell current data are
shown for 10 and 5 cells in black and gray symbols,
respectively. Panel C shows a b1 KO myotube transfected
with b2a (black traces) and a double dysgenic /b1 KO
myotube cotransfected with b2a and a1S (E1014K) (gray
traces). Panel D shows average ﬂuorescence versus volt-
age and current versus voltage curves for b1 KOmyotubes
expressing b2a (black traces) and for double dysgenic/b1
KO myotubes coexpressing b2a 1 a1S (E1014K) (gray
traces). Fluorescence and whole cell current data are
shown for 10 and 8 cells in black and gray symbols,
respectively. Parameters of the Boltzmann ﬁt of ﬂuores-
cence were DF/Fmax in DF/F units, V1/2 in mV, and k in
mV) were 46 0.6, 16 6, 86 1.1 (a1S (E1014K), 5 cells)
and 0.36 0.1, 246 5, 9.36 1.3 (b2a1 a1S (E1014K), 8
cells). Parameters for b1a and b2a expressing cells in b1
KO myotubes are shown in Table 2.
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was ;10-fold less effective as a trigger signal when the
skeletal DHPR included the cardiac/brain b2a isoform as a
b-subunit. This occurred despite the fact that Ca21 current
densities and previously estimated single-channel open
probabilities were similar when b2a replaced b1a in the
context of a WT a1S pore subunit (Beurg et al., 1999b).
Thus, DHPR densities were likely to be similar when either
b1a or b2a formed part of the DHPR complex. Based on
the small magnitude of the voltage-dependent component,
we would have predicted stronger differences in Ca21
transient amplitudes in b2a-expressing myotubes for 50-ms
and 200-ms depolarizations since the brief depolarization
injects between 5-fold and 130-fold less Ca21 charge into
the cell depending on channel kinetics (Sheridan et al.,
2003a). Instead, Fig. 6 shows only a twofold difference in
Ca21 transient ﬂuorescence at 130 mV for 50 ms and 200
ms in b2a-transfected b1 KO myotubes. It is entirely
possible that a voltage-activated Ca21 release component,
even if small, may lead to an explosive activation of near-
neighbor RyRs by a Ca21-dependent mechanism. Hence the
comparatively large activation of Ca21 release seen at 50
ms may not reﬂect the magnitude of the voltage-dependent
component. Rather, it may reﬂect the effect of the voltage-
dependent component on a much larger population of RyR
channels, most of them activated by Ca21 released from
a few voltage-activated RyRs. Such a mechanism has been
suggested for Ca21 spark formation in frog skeletal and
cardiac muscle. However, its applicability to mammalian
skeletal muscle still is under investigation (Stern et al., 1997).
It is also possible that the absence of normal interaction
between the DHPR and RyR1 when b2a is present renders
RyR1 more Ca21-sensitive such that smaller Ca21 currents
may recruit a larger density of Ca21-activated RyR channels.
Both possibilities suggest synergistic interactions between
voltage and Ca21 as trigger signals which remain to be
investigated in more detail.
The observed loss of voltage-dependent and gain of Ca21-
dependent EC coupling, in the context of a WT a1S-subunit,
implies a change in the mechanism of interaction of the
DHPR and RyR1. Structural studies have shown that, at
transverse tubular-SR junctions, four DHPRs arranged as
a square tetrad hover over the cytoplasmic surface of a sin-
gle RyR1 tetramer (reviewed by Franzini-Armstrong and
Protasi, 1997). This anatomical arrangement, and the
minimal distance separating the SR and surface-connected
membranes at these locations, has provided compelling
evidence in favor of a protein-to-protein ‘‘mechanical-type’’
coupling between the skeletal DHPR and RyR1. The EC
coupling signal transferred from the voltage sensor to RyR1
may thus involve some form of mechanical torque exerted on
the foot structure of RyR1 initiated by voltage sensor
movement. The essence of this concept was originally
proposed by Chandler et al. (1976), although the nature of
the protein complexes involved in voltage sensing and SR
Ca21 release were not known at the time. In this context, the
EC coupling changes promoted by b2a-subunit are most
easily visualized as a partial undocking of the DHPR and
RyR1 complexes. Ca21-dependent EC coupling might thus
result from a partially-docked DHPR-RyR1 complex in
which the voltage signal is unable to open a signiﬁcant
number of RyR1 channels. Those RyR1 channels not ac-
tivated by voltage might be available for activation by the
Ca21 current provided that the DHPR and the RyR1 re-
main co-localized. It could be further argued that in nor-
mal circumstances, the Ca21 current has no impact on EC
coupling because during a brief depolarization, and before
the full activation of the Ca21 current, the complete pool
of RyR channels in a given release unit is rapidly and
synchronically activated. Some of the RyR1 channels would
be directly activated by voltage via ‘‘mechanical’’ coupling
to the DHPR and others would be activated by the Ca21
released from the nearest voltage-activated RyR1 channel.
Rapid and synchronic activation of voltage-dependent and
Ca21-dependent RyR channels has been proposed to occur
during Ca21 spark formation in adult skeletal muscle (Stern
et al., 1997).
Expression of the native DHPR Ca21 current appears to be
under the speciﬁc control of RyR1 by a so-called retrograde
signal from RyR1 to the DHPR. This retrograde signal is
probably structural in origin since aWT Ca21 current density
was observed in RyR1 KO myotubes expressing RyR1
mutants deﬁcient in EC coupling (Avila et al., 2001). Recent
studies showed that the requirement of the DHPR for RyR1
could be bypassed by molecular determinants present on the
amino terminus of b2a (Ahern et al., 2003). Ca21 currents
were present at a WT density in RyR1 KO myotubes
overexpressing b2a or b2a-b1a chimeras carrying domains
D1, D2, and D3 of b2a (Ahern et al., 2003). Two vicinal
cysteines in domain D1, a putative palmitoylation motif,
were critical for the b2a-mediated Ca21 current recovery.
Furthermore, tethering b2a to the myotube surface by a
transmembrane motif in the absence of the two vicinal cys-
teines in domain D1 also increased Ca21 current expres-
sion in the absence of RyR1. Thus, the conformational state
of the b-subunit, or preferential locations of the b-subunit
close to the plasma membrane, are crucial for DHPR Ca21
current expression. In the native DHPR, such a speciﬁc con-
formation of the b-subunit may be reached through a
direct interaction with RyR1 (Cheng and Coronado, 2003).
However, we realize that Ca21 current regulation in the
skeletal DHPR is quite complex and that it involves
molecular determinants present in a1S (Grabner et al.,
1999), RyR1 (Nakai et al., 1998b), as well as in the b-sub-
unit (Ahern et al., 2003). Even though the mechanism for
Ca21 current enhancement by b2a has been outlined, it could
still be argued that b2a either recruited other pore subunits in
the culture myotube and/or redirected the DHPR to surface
locations away from EC coupling sites. Functional evidence
gathered previously (Ahern et al., 2003; Sheridan et al.,
2003a) and in this work, indicates that both possibilities are
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unlikely. As already mentioned, transfection of b1a in
a dysgenic a1S-null myotube does not result in expression of
Ca21 currents (not shown). Therefore, non-a1S pore sub-
units that could account for Ca21 current recovery by b2a
are not present in the cultured myotube. Furthermore, we
could not detect signiﬁcant differences in the skeletal-type
EC coupling abilities of b2a-b1a chimeras with and with-
out the double cysteine motif, provided that the carboxyl
terminus of b1a was present (Ahern et al., 2003). This result
argues that the double cysteine motif does not have an
intrinsic ability to relocate the DHPR to new sites in the
myotube surface away from the junctional SR region. These
reasons, and the fact that Ca21-dependent release was
observed, altogether, make it likely that hybrid DHPRs that
include a1S and b2a are present at SR junctions but are not
strongly docked to RyR1. Strong co-localization is a condi-
tion sine qua non for observing Ca21-dependent release
since other high-density Ca21 currents in the myotube such
as those originating from T-type Ca21 channels do not
release SR Ca21 (Ahern et al., 2001d).
This work implicates RyR3 in SR Ca21 release in cultured
skeletal myotubes. RyR3 is widely expressed in fetal limb
muscles, abdominal muscles, and in the diaphragm (Ber-
tocchini et al., 1997). During the neonatal phase, RyR3
expression is drastically reduced, whereas in the adult
musculature, this isoform is almost exclusively conﬁned to
the diaphragm and soleus muscles (Bertocchini et al., 1997;
Flucher et al., 1999). Hence, the presence of RyR3 in
cultured myotubes derived from limb fetal tissue is not
surprising, and our observation is in agreement with
a previous report (Takeshima et al., 1995). In b1a-over-
expressing and nontransfected RyR3 KO myotubes, the 200-
ms depolarization evoked more release, i.e., a higher DF/
Fmax, than the shorter 50-ms depolarization. This behavior
was not present in either WT or b1a-expressing b1 KO
myotubes (Table 1). RyR3 is known to form functional Ca21
release units, as demonstrated by its ability to generate
spontaneous Ca21 spark-like Ca21 release events in several
expression systems (Conklin et al., 2000; Ward et al., 2000;
Rossi et al., 2002). Furthermore, RyR3 is present in
transverse tubular-SR junctions (Flucher et al., 1999) and
contributes substantially to the kinetics and overall dimen-
sions of Ca21 sparks in WT muscle cells (Conklin et al.,
2000). In cultured myotubes, Ca21 release sites are present in
peripheral couplings established between junctional SR and
surface membranes (Takekura et al., 1994). Confocal studies
in cultured myotubes have shown that the rate of SR Ca21
release propagation from the edge to the center of the cell is
considerably slower in RyR3 KO than in RyR3-expressing
controls. Thus, a signiﬁcant functional role of RyR3
channels is to synchronize the macroscopic Ca21 release
transient in different regions of the myotube (Yang et al.,
2001). Our ﬁndings are consistent with this observation,
since a brief depolarization is expected to be less effective
than a longer depolarization in speeding inward Ca21 release
propagation. In our data, this would be manifested as
a decrease in the space-averaged ﬂuorescence. It is in-
teresting to note that a decrease in space-averaged Ca21
ﬂuorescence is also evident in the line scan images in Fig. 1 B
of Yang et al. (2001) comparing RyR3-deﬁcient and RyR3-
expressing myotubes, although calculations were not
reported. Mammalian RyR3 channels have a mean open
time much longer than RyR1 channels (Chen et al., 1997)
and a lower sensitivity to inactivation by Ca21 (Sonnleitner
et al., 1998) and Mg21 (Murayama and Ogawa, 1997). We
would speculate that during a Ca21 transient, RyR3 channels
remain open for longer periods than RyR1 channels. The
overall result would be a local positive reinforcement of
Ca21 release, and this could be the basis for the enhancement
in Ca21 ﬂuorescence observed with the 200-ms depolariza-
tion. Our observations in RyR1 KO myotubes further
indicate that RyR3 is capable of engaging in Ca21 release
triggered directly by the Ca21 current. Hence, RyR3 may not
only amplify Ca21 release initiated by RyR1, but, in
addition, RyR3 may be a recipient of a bona ﬁde Ca21
current trigger signal.
The changes in the EC coupling trigger signal, from
voltage to Ca21 entry, promoted by b2a in b1 KOmyotubes,
are entirely analogous to the changes in EC coupling
observed previously when a1S was replaced by the cardiac
a1C-subunit in the cellular context of a primary dysgenic
a1S-null skeletal myotube (Tanabe et al., 1990; Garcia et al.,
1994). The functional analogy extends also to Ca21 current
regulation since a1C, like b2a, expresses high-density Ca21
currents in RyR1 KO myotubes (Carbonneau et al., 2003;
unpublished). Hence, Ca21 current expression in a DHPR
that includes a1C is not functionally inhibited by the absence
of RyR1. The similar outcome of these two sets of ex-
periments, namely a1S replacement by a1C versus b1a re-
lacement by b2a, suggests to us that in the native DHPR,
critical interactions with RyR1 responsible for orthograde and
retrograde coupling are controlled by conformational states in
botha1S and theb-subunit. Hence, wewould suggest that the
a1S/b pair, and not each subunit alone, controls the EC
coupling signal in skeletal myotubes. Whether the role of the
b-subunit is to facilitate DHPR-RyR1 docking, i.e., a struc-
tural role, or is directly involved in the transmission of the
molecular signal to RyR1, is currently under investigation.
Both possibilities are suggested by mutagenesis experiments
in which deletion of EC domains present in thea1S II-III loop
did not entirely abolish voltage-dependent Ca21 transients
(Ahern et al., 2001b) and by the fact that b1a binds directly to
RyR1 (Cheng and Coronado, 2003).
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